AU7508100A - Human seizure related proteins - Google Patents
Human seizure related proteinsInfo
- Publication number
- AU7508100A AU7508100A AU75081/00A AU7508100A AU7508100A AU 7508100 A AU7508100 A AU 7508100A AU 75081/00 A AU75081/00 A AU 75081/00A AU 7508100 A AU7508100 A AU 7508100A AU 7508100 A AU7508100 A AU 7508100A
- Authority
- AU
- Australia
- Prior art keywords
- related proteins
- seizure related
- human seizure
- human
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199901420 | 1999-10-04 | ||
DKPA199901420 | 1999-10-04 | ||
PCT/DK2000/000556 WO2001025268A1 (en) | 1999-10-04 | 2000-10-04 | Human seizure related proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7508100A true AU7508100A (en) | 2001-05-10 |
Family
ID=8104646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75081/00A Abandoned AU7508100A (en) | 1999-10-04 | 2000-10-04 | Human seizure related proteins |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7508100A (en) |
WO (1) | WO2001025268A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2001063293A2 (en) * | 2000-02-24 | 2001-08-30 | Oxford Glycosciences (Uk) Ltd. | Diagnosis and treatment of schizophrenia |
AU2001256977A1 (en) * | 2000-04-28 | 2001-11-12 | Eli Lilly And Company | Human sez6 nucleic acids and polypeptides |
EP1355158A1 (en) | 2002-04-19 | 2003-10-22 | B.R.A.H.M.S Aktiengesellschaft | Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker |
GB0510089D0 (en) * | 2005-05-17 | 2005-06-22 | Celltech R&D Ltd | A protein involved in cancer |
WO2007116923A2 (en) * | 2006-03-31 | 2007-10-18 | Oncotherapy Science, Inc. | Sez6l2 oncogene as a therapeutic target and prognostic indicator for lung cancer |
EP3389630B1 (en) | 2015-12-16 | 2023-11-08 | Gritstone bio, Inc. | Neoantigen identification, manufacture, and use |
EP3694532B1 (en) | 2017-10-10 | 2025-02-26 | Gritstone bio, Inc. | Neoantigen identification using hotspots |
CA3083097A1 (en) | 2017-11-22 | 2019-05-31 | Gritstone Oncology, Inc. | Reducing junction epitope presentation for neoantigens |
-
2000
- 2000-10-04 AU AU75081/00A patent/AU7508100A/en not_active Abandoned
- 2000-10-04 WO PCT/DK2000/000556 patent/WO2001025268A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001025268A1 (en) | 2001-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1473501A (en) | 21 human secreted proteins | |
AU1604401A (en) | 18 human secreted proteins | |
AU1438001A (en) | 27 human secreted proteins | |
AU6045900A (en) | Interaction-activated proteins | |
AU1448701A (en) | 15 human secreted proteins | |
AU1334101A (en) | 19 human secreted proteins | |
AU1608201A (en) | Human zven proteins | |
AU3393900A (en) | Human secretory proteins | |
AU5744200A (en) | Human transport proteins | |
AU2757500A (en) | 33 human secreted proteins | |
AU4338100A (en) | Secreted human proteins | |
AU2067501A (en) | Human oxidoreductase proteins | |
AU1918601A (en) | 23 human secreted proteins | |
AU7508100A (en) | Human seizure related proteins | |
AU3609300A (en) | Human serpin proteins | |
AU1916101A (en) | 19 human secreted proteins | |
AU7089800A (en) | 29 human cancer associated proteins | |
AU1342501A (en) | 32 human secreted proteins | |
AU4483500A (en) | Human membrane-associated proteins | |
AU3249300A (en) | 47 human secreted proteins | |
AU3396600A (en) | 49 human secreted proteins | |
AU3208700A (en) | 33 human secreted proteins | |
AU1881200A (en) | Novel proteins | |
AU1449001A (en) | 28 human secreted proteins | |
AU1472801A (en) | 24 human secreted proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |